Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Activity of XmAb24306 in Combination With Cevostamab in Participants With Relapsed/Refractory Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety, pharmacokinetics, and activity of XmAb24306 in combination with cevostamab in participants with relapsed/refractor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Cevostamab (cevostamab)
• XMAB24306

Snippet

Sponsor: Genentech, Inc. | Conditions: Multiple Myeloma | Phase 1 | Status: ACTIVE_NOT_RECRUITING